Skip to content

The effect of Intensive Neuromotor Therapies for postural control in children with Cerebral Palsy

Effectiveness of Intensive Neuromotor Therapies for postural control of children with Chronic Non Progressive Encephalopathy of Childhood

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7sjynm5
Enrollment
Unknown
Registered
2024-03-14
Start date
2024-02-20
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postural Balance

Interventions

This study has experimental characteristics, as it involves an intervention This is a non-randomized clinical trial with two groups: intervention group (IG), which will participate in intensive physio
E02.760.169.063.500.387.875

Sponsors

UNISSUAM
Lead Sponsor
Universidade Federal do Ceará
Collaborator

Eligibility

Age
3 Years to 8 Years

Inclusion criteria

Inclusion criteria: Children diagnosed with Cerebral Palsy; Age range from 3 to 8 years; Both sexes; Gross Motor Function Classification System from 1 to 5

Exclusion criteria

Exclusion criteria: Subjects who are not interested in participating in the research; Children who have contraindications to carrying out the protocols intensive using the suit

Design outcomes

Primary

MeasureTime frame
Functional capacity is expected to be measured using the GMFM-66 Gross Motor Function Scale. Assessment of balance control in standing using posturographic parameters. In addition, qualitative assessment of postural balance using the Pediatric Balance Scale

Secondary

MeasureTime frame
Assessment of neuromuscular control using the phyphox application. Determination of lower limb muscle strength using dynamometry. Finally, correlation of quantitative indicators of motor function with the GMFM-66 Gross Motor Function Scale

Countries

Brazil

Contacts

Public ContactKaren Saraiva

UNISSUAM

propac.ufc@gmail.com552138829797

Outcome results

None listed

Source: REBEC (via WHO ICTRP)